Sam Molyneux is the CEO and Co-Founder of Meta – an AI company in the science and IP market that solves core information challenges for academics and industries built on scientific information. Inspired by the challenges he faced as a PhD student in cancer genomics at the University of Toronto, Sam co-founded Meta in 2010. The company has since been covered in Wired, Wired UK and TechCrunch. Meta’s free literature discovery engine is used by researchers at thousands of institutes around the world, while Meta’s platform AI and data services are used by industries like publishing, life sciences, and government. Meta’s mission is to unlock all of the world’s scientific and technical insights using AI. Sam’s research in cancer genomics has been published in Nature Genetics, Nature Cell Biology, PNAS and the Journal of Clinical Investigation.
In Partnership with:
In Collaboration with: